A blood transfusion for leukemia replaces the red blood cells or platelets that the bone marrow cannot make while leukemia, or its treatment, is suppressing it. Most people with acute leukemia need transfusions during chemotherapy, and many with chronic leukemia or relapsed disease need them at some stage. Transfusions do not treat the leukemia itself; they keep you safe from severe anemia and bleeding while other treatments do that work.
In my practice, transfusion is one of the most routine parts of leukemia treatment, and one patients ask about most. This guide explains why it is needed, which products are used, how decisions are made and what the risks are.
Why People With Leukemia Need Transfusions
Leukemia is a cancer of blood-forming cells in which abnormal white blood cells multiply out of control. These cells crowd the bone marrow, leaving less room and support for normal production of red cells, platelets and healthy white cells.
Chemotherapy, radiation and stem cell transplant add to the problem. They are designed to kill rapidly dividing cells, and healthy marrow is among them. After intensive chemotherapy, blood counts typically fall to their lowest point, the nadir, within one to two weeks before recovering.
The result is one or more cytopenias, or low blood counts:
- Anemia (low red cells): tiredness, breathlessness, pale skin, dizziness and a fast heartbeat.
- Thrombocytopenia (low platelets): easy bruising, tiny red-purple skin spots called petechiae, nosebleeds and bleeding gums.
- Neutropenia (low neutrophils): a high risk of serious infection. This is managed with antibiotics and growth factors rather than routine transfusion.
Types of Blood Products Used
| Product | What it treats | Typical use in leukemia |
|---|---|---|
| Red blood cells | Anemia | Symptoms of anemia or hemoglobin below the target threshold |
| Platelets | Low platelets, bleeding | Preventing bleeding at very low counts, before procedures, or during active bleeding |
| Fresh frozen plasma | Clotting factor deficiency | Bleeding with abnormal clotting tests |
| Cryoprecipitate | Low fibrinogen | Coagulopathy, especially in acute promyelocytic leukemia |
| Granulocytes | Severe neutropenia with infection | Rarely used, for infections not responding to treatment |
Red cells and platelets account for nearly all transfusions in leukemia care. Plasma and cryoprecipitate are used when clotting is disturbed, as in disseminated intravascular coagulation (DIC).
When Is a Transfusion Given?
Decisions are based on blood counts together with how you feel. Your team checks a complete blood count frequently during treatment, often daily in hospital, and tracks hemoglobin and platelet levels alongside clotting tests.
| Situation | Common threshold |
|---|---|
| Red cells, stable patient | Hemoglobin below about 7 to 8 g/dL, or symptoms of anemia |
| Red cells, heart disease or symptoms | A higher threshold set by the treating team |
| Platelets, preventive | Below 10 x 10^9/L in a stable patient |
| Platelets, fever, infection or APL | Higher thresholds, often 20 to 50 x 10^9/L |
| Platelets, procedures or active bleeding | Commonly 50 x 10^9/L or more |
For context, normal adult hemoglobin is roughly 12 to 16 g/dL in women and 13.5 to 17.5 g/dL in men, and a normal platelet count is about 150 to 400 x 10^9/L. You can read more about PLT levels and what they mean. Hospitals set their own exact thresholds, so yours may differ slightly.
One special case is hyperleukocytosis, a very high leukemic white count. Red cell transfusions are given cautiously here because they can thicken the blood further.
Special Blood Products for Leukemia Patients
People with leukemia often receive specially processed blood to reduce specific risks:
- Leukoreduced blood has most donor white cells filtered out. This lowers the risk of fevers, of developing antibodies to platelets and of transmitting cytomegalovirus (CMV).
- Irradiated blood is treated so donor lymphocytes cannot multiply. It prevents transfusion-associated graft-versus-host disease, a rare but serious complication. It is standard for stem cell transplant recipients and for people treated with certain drugs such as fludarabine.
- HLA-matched platelets are used when a patient has developed antibodies and no longer responds to standard platelet units, a problem called platelet refractoriness.
If you have had a transplant, your blood group may change over time, and the blood bank will choose compatible products accordingly.
What to Expect During a Transfusion
Before any transfusion, a sample is taken for a type and screen and crossmatch to confirm your blood group and check for antibodies. Staff will check your identity carefully at every step.
The product is given through an IV line or central venous catheter. A unit of red cells usually runs over one to three hours, and a unit of platelets takes about 30 to 60 minutes. Nurses check your temperature, pulse and blood pressure before, during and after. In a typical adult, one unit of red cells raises hemoglobin by about 1 g/dL.
Risks and Long-Term Considerations
Transfusions in modern blood services are very safe, but they are not risk-free.
- Febrile and allergic reactions: fever, chills, itching or hives. These are the most common and are usually mild.
- Fluid overload: breathlessness from too much volume, more likely in older adults or those with heart disease.
- Alloimmunization: antibodies against donor cells that make future matching harder.
- Iron overload: each red cell unit adds iron that the body cannot excrete. Patients needing many transfusions over time may need iron chelation.
- Infection: very rare with modern donor screening and testing.
Some treatments can reduce transfusion needs in selected patients. Erythropoiesis-stimulating agents and thrombopoietin receptor agonists are sometimes used, though their role in leukemia is limited and depends on the specific disease.
When to Contact Your Care Team
Tell your nurse at once if you develop chills, fever, rash, back pain, chest tightness or breathlessness during a transfusion. Between transfusions, seek urgent care for bleeding that will not stop, black stools, blood in urine, a severe headache, or fever of 38 °C (100.4 °F) or higher while your counts are low.
Frequently Asked Questions
How often will I need a blood transfusion for leukemia?
It depends on the type of leukemia and the treatment phase. During intensive chemotherapy for acute leukemia, some patients need red cells or platelets several times a week. Once the marrow recovers, most stop needing them.
Does needing transfusions mean my leukemia is getting worse?
Not necessarily. Transfusions are expected during chemotherapy because treatment temporarily suppresses the marrow. A rising need outside treatment, however, can be a sign worth discussing with your hematologist, along with your blood test for leukemia results.
Can family members donate blood for me?
Directed donation is possible in some places, but it is not usually safer than volunteer blood. Blood from relatives must be irradiated, and it may be discouraged if a family member could later be a stem cell donor.
Will a transfusion make me feel better right away?
Many people notice more energy and less breathlessness within a day of a red cell transfusion. Platelet transfusions do not change how you feel but reduce bleeding risk.
